Stephen F. Betz - Net Worth and Insider Trading

Stephen F. Betz Net Worth

The estimated net worth of Stephen F. Betz is at least $4 Million dollars as of 2024-11-29. Stephen F. Betz is the Chief Scientific Officer of Crinetics Pharmaceuticals Inc and owns about 68,576 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $4 Million. Details can be seen in Stephen F. Betz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen F. Betz has not made any transactions after 2024-09-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Stephen F. Betz

To

Stephen F. Betz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen F. Betz owns 1 companies in total, including Crinetics Pharmaceuticals Inc (CRNX) .

Click here to see the complete history of Stephen F. Betz’s form 4 insider trades.

Insider Ownership Summary of Stephen F. Betz

Ticker Comapny Transaction Date Type of Owner
CRNX Crinetics Pharmaceuticals Inc 2024-09-10 Chief Scientific Officer

Stephen F. Betz Latest Holdings Summary

Stephen F. Betz currently owns a total of 1 stock. Stephen F. Betz owns 68,576 shares of Crinetics Pharmaceuticals Inc (CRNX) as of September 10, 2024, with a value of $4 Million.

Latest Holdings of Stephen F. Betz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRNX Crinetics Pharmaceuticals Inc 2024-09-10 68,576 57.67 3,954,778

Holding Weightings of Stephen F. Betz


Stephen F. Betz Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen F. Betz has made a total of 42 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 0 buys and 42 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 1,035 shares on September 10, 2024, which brought Stephen F. Betz around $53,303.

Insider Trading History of Stephen F. Betz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen F. Betz Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephen F. Betz Ownership Network

Ownership Network List of Stephen F. Betz

No Data

Ownership Network Relation of Stephen F. Betz

Insider Network Chart

Stephen F. Betz Owned Company Details

What does Crinetics Pharmaceuticals Inc do?

Who are the key executives at Crinetics Pharmaceuticals Inc?

Stephen F. Betz is the Chief Scientific Officer of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include Chief Operating Officer Jeff E. Knight , Chief Development Officer Dana Pizzuti , and See Remarks Marc Wilson .

Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary

Over the past 18 months, Stephen F. Betz made 14 insider transaction in Crinetics Pharmaceuticals Inc (CRNX) with a net sale of 40,035. Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 159,049 shares made by Marc Wilson , a net sale of 91,672 shares made by Dana Pizzuti , and a net sale of 448,399 shares made by Richard Scott Struthers .

In summary, during the past 3 months, insiders sold 40,911 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 40,911 shares. During the past 18 months, 914,471 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 909,471 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Crinetics Pharmaceuticals Inc Insider Transactions

No Available Data

Stephen F. Betz Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen F. Betz. You might contact Stephen F. Betz via mailing address: 10222 Barnes Canyon Road, Building 2, San Diego Ca 92121.

Discussions on Stephen F. Betz

No discussions yet.